News & Media

This week marks the 15th anniversary of Joslin’s Why WAIT program, one of the longest-running programs in Joslin’s history. Why WAIT started on September 28th, 2005 as the world’s first...

We are pleased to share that Joslin has once again been acknowledged by the National Committee for Quality Assurance’s (NCQA) Diabetes Recognition Program (DRP) for the high-quality care provided by...

Renowned businessman was leader in health care philanthropy BOSTON – (September 21, 2020) — Joslin Diabetes Center, an affiliate of Harvard Medical School, mourns the loss of Richard A. “Dick” Smith...

At Joslin Diabetes we are committed to providing the very best and safest care possible. In response to the COVID-19 pandemic, Joslin has developed a hybrid model of care for our patients. Our hybrid...

Dr. Toschi and Dr Munshi from the Joslin Diabetes Center provide insight on CGM metrics and risk of hypoglycemia in older patients with type 1 diabetes, a post-hoc analysis a baseline data of our...

Joslin Diabetes Center (“Joslin”) is providing notice of a cyber incident that may affect the security of some information relating to certain individuals associated with Joslin, including donors and...

BOSTON – (September 3, 2020) – Using cells taken from patients with type 2 diabetes and new techniques to convert them into specialized precursors of muscle cells, researchers have developed a novel...

Studies in mice offer a proof of concept that ‘HUMBLE’ cells, created from human white fat, can treat metabolic diseases. BOSTON – (August 26, 2020) – Obesity is the main cause of type 2 diabetes and...

Persis Commissariat, PhD, a pediatric clinical health psychologist here at Joslin, works with families to help navigate the challenges of raising and being, a child with type 1 diabetes. Read about...

An existing drug boosts survival for insulin-producing cells under autoimmune attack. BOSTON – (July 27, 2020) – Type 1 diabetes occurs when a person’s own immune system destroys insulin-producing...

Dr. Jennifer K. Sun, MD, MPH has been promoted to Senior Investigator within the Research Section of the Joslin Diabetes Center. This prestigious appointment recognizes sustained excellence in...

Cinnamon may improve blood sugar control in people with a condition known as prediabetes and may slow the progression to type 2 diabetes, according to a new pilot study of 51 people with elevated...

Joslin research in mice and humans shows an adverse effect that begins in pre-diabetes and is independent of obesity. BOSTON – (July 20, 2020) – Every doctor recommends regular aerobic exercise, since...

Women with a history of gestational diabetes were 50% more likely to have a short interval between pregnancies (18 months or less) compared with women without gestational diabetes, in a new study.

Study Highlights: Largest US database of pregnant women with type 1 diabetes provides a first-time, big picture view of mother’s health, and neonatal and delivery outcomes. The analysis found a...